197 related articles for article (PubMed ID: 3917458)
21. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
Gelato MC; Oldfield E; Loriaux DL; Merriam GR
J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
[TBL] [Abstract][Full Text] [Related]
22. Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment.
Boizel R; Halimi S; Labat F; Cohen R; Bachelot I
J Clin Endocrinol Metab; 1987 Feb; 64(2):304-8. PubMed ID: 3098773
[TBL] [Abstract][Full Text] [Related]
23. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
24. Regulation of pulsatile growth hormone secretion by fasting in normal subjects and patients with acromegaly.
Ho PJ; Friberg RD; Barkan AL
J Clin Endocrinol Metab; 1992 Sep; 75(3):812-9. PubMed ID: 1517371
[TBL] [Abstract][Full Text] [Related]
25. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
[TBL] [Abstract][Full Text] [Related]
26. The role of endogenous growth hormone-releasing hormone in acromegaly.
Dimaraki EV; Chandler WF; Brown MB; Jaffe CA; Kim SY; Taussig R; Padmanabhan V; Barkan AL
J Clin Endocrinol Metab; 2006 Jun; 91(6):2185-90. PubMed ID: 16537684
[TBL] [Abstract][Full Text] [Related]
27. Failure to respond to growth hormone releasing hormone (GHRH) in acromegaly due to a GHRH secreting pancreatic tumor: dynamics of multiple endocrine testing.
Schulte HM; Benker G; Windeck R; Olbricht T; Reinwein D
J Clin Endocrinol Metab; 1985 Sep; 61(3):585-7. PubMed ID: 3926812
[TBL] [Abstract][Full Text] [Related]
28. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion.
Barkan AL; Shenker Y; Grekin RJ; Vale WW; Lloyd RV; Beals TF
J Clin Endocrinol Metab; 1986 Nov; 63(5):1057-64. PubMed ID: 3093517
[TBL] [Abstract][Full Text] [Related]
29. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy.
Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G
J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356
[TBL] [Abstract][Full Text] [Related]
30. Modulation by glucocorticoids of growth hormone secretion in patients with different pituitary tumors.
Popovic V; Damjanovic S; Micic D; Manojlovic D; Micic J; Casanueva FF
Neuroendocrinology; 1993 Oct; 58(4):465-72. PubMed ID: 8284031
[TBL] [Abstract][Full Text] [Related]
31. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
[TBL] [Abstract][Full Text] [Related]
32. Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors.
Ho PJ; Jaffe CA; Friberg RD; Chandler WF; Barkan AL
J Clin Endocrinol Metab; 1994 Jun; 78(6):1403-10. PubMed ID: 7911124
[TBL] [Abstract][Full Text] [Related]
33. Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion.
Moller DE; Moses AC; Jones K; Thorner MO; Vance ML
J Clin Endocrinol Metab; 1989 Feb; 68(2):499-504. PubMed ID: 2493033
[TBL] [Abstract][Full Text] [Related]
34. Human growth hormone-secreting pituitary adenoma cells in long-term culture: effects of dexamethasone and growth hormone releasing factor.
Oosterom R; Verleun T; Lamberts SW
J Endocrinol; 1984 Mar; 100(3):353-60. PubMed ID: 6421977
[TBL] [Abstract][Full Text] [Related]
35. Responses of growth hormone (GH) and somatomedin-C to GH-releasing hormone in healthy aging men.
Pavlov EP; Harman SM; Merriam GR; Gelato MC; Blackman MR
J Clin Endocrinol Metab; 1986 Mar; 62(3):595-600. PubMed ID: 3080468
[TBL] [Abstract][Full Text] [Related]
36. Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegaly.
Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Liuzzi A; Chiodini PG
J Clin Endocrinol Metab; 1986 Mar; 62(3):601-4. PubMed ID: 3080469
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone.
Hofland LJ; van Koetsveld PM; van Vroonhoven CC; Stefanko SZ; Lamberts SW
J Clin Endocrinol Metab; 1989 Mar; 68(3):613-20. PubMed ID: 2493040
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels.
Yamashita S; Melmed S
Endocrinology; 1986 Jan; 118(1):176-82. PubMed ID: 3079701
[TBL] [Abstract][Full Text] [Related]
39. Evidence for the release of a novel pituitary polypeptide (7B2) from the growth hormone-producing pituitary adenoma of patients with acromegaly.
Natori S; Iguchi H; Nawata H; Kato K; Ibayashi H; Nakagaki H; Chrétien M
J Clin Endocrinol Metab; 1988 Feb; 66(2):430-7. PubMed ID: 3123513
[TBL] [Abstract][Full Text] [Related]
40. Biphasic effects of dexamethasone on growth hormone release in vitro.
Nakagawa K; Akikawa K; Matsubara M; Kubo M; Ishizuka T; Obara T
Endocrinol Jpn; 1987 Dec; 34(6):947-53. PubMed ID: 2836185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]